Clinical trial Recruiting at 1 site Interventional

Short motivational coaching to help cancer survivors be more active

Official title: Effectiveness and Implementation of a Brief Motivational Intervention to Increase Physical Activity for World Trade Center Health Program Cancer Survivors

Run by Stony Brook University · NCT07215091 · Data updated 2026-11-12

This project will try a brief motivational coaching program to help World Trade Center Health Program cancer survivors increase and keep up their physical activity.

Quick facts

Study typeInterventional
SexAll
Enrollment84 (estimated)
SponsorStony Brook University
Academic / other
Locations1 site (Stony Brook, New York)
StatusRecruiting
StartedJanuary 4, 2025
Main results expectedJuly 1, 2026
Study endsJuly 1, 2026
Registry record updatedOctober 14, 2025
Trial IDNCT07215091 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are WTCHP-enrolled adults who have completed cancer treatment, can walk at least slowly, read and speak English, and are not receiving active treatment or have metastatic disease.

Probably not a fit

Patients currently receiving active cancer treatment (except hormonal therapy), with late-stage metastatic disease, unable to exercise safely, unable to attend required visits, pregnant, or non-English speakers are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional program tests a brief motivational intervention to initiate and maintain physical activity among cancer survivors enrolled in the World Trade Center Health Program. Eligible participants are WTCHP members with a history of cancer who have completed active treatment and are physically able to walk slowly; people with metastatic disease, those receiving active non-hormonal treatment, pregnant women, non-English speakers, or those unsafe to exercise are excluded. The intervention uses short, evidence-based motivational counseling delivered at the point of care to encourage regular physical activity and address barriers to exercise. Outcomes focus on changes in activity behavior and physical function over the study period.

Why it matters

Potential benefit: If successful, the intervention could help cancer survivors increase and sustain physical activity, which may improve physical function, symptoms, and overall quality of life.

How similar studies have gone: Brief motivational and counseling interventions have shown modest success in increasing physical activity among cancer survivors and other chronic disease groups, so this approach is evidence-informed though not yet widely implemented in the WTCHP.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participation in the World Trade Center Health Program
* History of cancer, completed treatment
* Ability to be physically active (at minimum be able to walk slowly)

Exclusion Criteria:

* Participants receiving active cancer treatment (excluding hormonal therapy);
* Late-stage cancer (metastatic);
* Inability to follow the scheduled visits;
* Women who are pregnant
* Patients who would not be safe exercising without medical supervision (ECOG score of 3, significant comorbidities, unable to even walk slowly)
* Inability to speak and read English.

Where it's running

  • Stony Brook University
    Stony Brook, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.